Growth Metrics

Erasca (ERAS) Non-cash Items (2020 - 2026)

Erasca posted quarterly Non-cash Items of $106.4 million for Q1 2026, up 8384.85% year-on-year from $1.3 million in Q1 2025, and up 72.56% on a QoQ basis from $61.7 million in Q4 2025.

Erasca (ERAS) has 7 years of Non-cash Items data on file, last reported at $106.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-cash Items rose 8384.85% year-over-year to $106.4 million; the trailing twelve-month figure through Mar 2026 stood at $106.4 million (up 8384.85% YoY), and the FY2025 full-year result was $61.7 million, up 374.7% from the prior year.
  • Non-cash Items for Q1 2026 stood at $106.4 million, up from $61.7 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $106.4 million in Q1 2026 and bottomed at $880000.0 in Q2 2025.
  • The 5-year median for Non-cash Items is $11.6 million (2024), against an average of $24.2 million.
  • The widest annual swing landed in 2025, when Non-cash Items sank 92.4%; it then jumped 8384.85% in 2026.
  • A 5-year view of Non-cash Items shows it stood at $18.3 million in 2022, then plunged by 75.88% to $4.4 million in 2023, then jumped by 194.4% to $13.0 million in 2024, then soared by 374.7% to $61.7 million in 2025, then jumped by 72.56% to $106.4 million in 2026.
  • The last three Non-cash Items figures came in at $106.4 million (Q1 2026), $61.7 million (Q4 2025), and $14.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Erasca 4.21 Bn 3.97 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 106.40 Mn
Mar 31, 2026 106.40 Mn
Dec 31, 2025 61.66 Mn
Dec 31, 2025 61.66 Mn
Sep 30, 2025 14.58 Mn
Sep 30, 2025 14.58 Mn
Jun 30, 2025 880,000.00
Jun 30, 2025 880,000.00
Mar 31, 2025 1.25 Mn
Mar 31, 2025 1.25 Mn
Dec 31, 2024 12.99 Mn
Dec 31, 2024 12.99 Mn
Sep 30, 2024 16.77 Mn
Sep 30, 2024 16.77 Mn
Jun 30, 2024 11.58 Mn
Jun 30, 2024 11.58 Mn
Mar 31, 2024 7.53 Mn
Mar 31, 2024 7.53 Mn
Dec 31, 2023 4.41 Mn
Dec 31, 2023 4.41 Mn
Sep 30, 2023 10.54 Mn
Sep 30, 2023 10.54 Mn
Jun 30, 2023 62.50 Mn
Jun 30, 2023 62.50 Mn
Mar 31, 2023 8.17 Mn
Mar 31, 2023 8.17 Mn
Dec 31, 2022 18.30 Mn
Dec 31, 2022 18.30 Mn
Sep 30, 2022 6.54 Mn
Sep 30, 2022 6.54 Mn
Jun 30, 2022 5.70 Mn
Jun 30, 2022 5.70 Mn
Mar 31, 2022 62.40 Mn
Mar 31, 2022 62.40 Mn
Dec 31, 2021 163.26 Mn
Dec 31, 2021 163.26 Mn
Sep 30, 2021 32.30 Mn
Sep 30, 2021 32.30 Mn
Jun 30, 2021 1.90 Mn
Jun 30, 2021 1.90 Mn
Dec 31, 2020 15.57 Mn
Dec 31, 2020 15.57 Mn